Home › Funds › ACUTA CAPITAL PARTNERS, LLC › ARTV

ACUTA CAPITAL PARTNERS, LLC position in ARTV

ARTIVA BIOTHERAPEUTICS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 260,416 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 1.76% of its reported portfolio and ranking #19 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed ARTV holdings in 5 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)260.42K sh
Reported value held$2.53M
Portfolio Weight1.76%
First reportedQ3 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's ARTV position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in ARTV in Q3 2024 at 44,000 shares (US$680K). The position peaked in Q2 2026 at 260,416 shares, worth US$2.5M. Across 5 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 260,416 shares valued at US$2.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 44.00K $679.80K New
Q4 2024 44.00K $443.52K Hold
Q1 2025 45.46K $136.37K Add
Q2 2025 45.46K $68.64K Hold
Q2 2026 260.42K $2.53M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARTV and 13F data

ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARTV

All ARTV fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held ARTV?

ACUTA CAPITAL PARTNERS, LLC has disclosed ARTV holdings in 5 of the last 8 reported quarters, going back to Q3 2024.

What is ACUTA CAPITAL PARTNERS, LLC's current position in ARTV?

As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 260.42K shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $2.53M, representing 1.76% of its reported portfolio and ranking #19.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling ARTV?

In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in ARTV. The position peaked in Q2 2026 at 260.42K shares.

Which other funds hold ARTV?

Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.